Numerous studies have revealed that elevated serum YKL‐40 is associated with disease severity, which may correspond to poor prognosis in many diseases, including cancer, type 2 diabetes, and coronary artery disease [23, 24, 25]. Here, CHI3L1 is linked to type 2 diabetes mellitus.